Statins may increase risk for Diabetes & Memory Loss
Early last week, the US Food and Drug Administration (FDA) announced their addition of warning labels on statins, a group of cholesterol lowering drugs. The action comes on the heels of the agency’s review of medical literature, clinical trial data, and reports of adverse events leading to increased levels of blood sugar and potential memory […]